QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.55%)
BABA   74.68 (-2.68%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.71%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+6.86%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)
QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.55%)
BABA   74.68 (-2.68%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.71%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+6.86%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)
QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.55%)
BABA   74.68 (-2.68%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.71%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+6.86%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)
QQQ   389.81 (-0.10%)
AAPL   189.37 (-0.54%)
MSFT   378.85 (-1.01%)
META   332.20 (-2.00%)
GOOGL   134.99 (-1.61%)
AMZN   146.32 (-0.48%)
TSLA   244.14 (-1.05%)
NVDA   481.40 (+0.67%)
NIO   7.18 (-0.55%)
BABA   74.68 (-2.68%)
AMD   123.85 (+1.51%)
T   16.30 (+0.74%)
F   10.59 (+2.12%)
MU   76.69 (+0.75%)
CGC   0.56 (+3.71%)
GE   118.86 (+0.01%)
DIS   92.50 (+0.00%)
AMC   7.17 (+6.86%)
PFE   30.08 (+1.31%)
PYPL   57.97 (-0.86%)
XOM   102.34 (-1.50%)

Innospec Stock Price, News & Analysis (NASDAQ:IOSP)

$104.87
-0.68 (-0.64%)
(As of 11/29/2023 ET)
Compare
Today's Range
$104.68
$106.77
50-Day Range
$96.36
$109.26
52-Week Range
$91.74
$116.00
Volume
48,873 shs
Average Volume
83,442 shs
Market Capitalization
$2.61 billion
P/E Ratio
20.64
Dividend Yield
1.37%
Price Target
N/A

Innospec MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.57% of Float Sold Short
Dividend Strength
Moderate
Based on Four Factors
Sustainability
N/A
News Sentiment
1.55mentions of Innospec in the last 14 days
Based on 3 Articles This Week
Insider Trading
Selling Shares
$99,205 Sold Last Quarter
Proj. Earnings Growth
12.82%
From $5.85 to $6.60 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.20 out of 5 stars

Basic Materials Sector

2nd out of 166 stocks

Chemicals & Allied Products Industry

1st out of 15 stocks


IOSP stock logo

About Innospec Stock (NASDAQ:IOSP)

Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in various fuels. This segment's products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Its Performance Chemicals segment provides technology-based solutions for its customers' processes or products that focuses on the personal care, home care, agrochemical, and metal extraction markets. The company's Oilfield Services segment develops and markets chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, as well as products to prevent loss of mud in drilling operations. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.

IOSP Stock Price History

IOSP Stock News Headlines

Innospec Inc's Dividend Analysis
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Innospec Inc IOSP
Q3 2023 Innospec Inc Earnings Call
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Innospec Reports Third Quarter 2023 Financial Results
Innospec Non-GAAP EPS of $1.59, revenue of $464.1M
Innospec (NASDAQ: IOSP)
Innospec Publishes 2022 ESG Report
Q2 2023 Innospec Inc Earnings Call
Innospec (IOSP) Q2 Earnings Surpass Estimates
Innospec Reports Second Quarter 2023 Financial Results
Albemarle (ALB) Q2 Earnings Surpass Estimates
See More Headlines
Receive IOSP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Innospec and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/07/2023
Ex-Dividend for 11/27 Dividend
11/17/2023
Dividend Payable
11/27/2023
Today
11/29/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/20/2024

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
Specialty Chemicals
Current Symbol
NASDAQ:IOSP
CUSIP
45768S10
Employees
2,100
Year Founded
1938

Profitability

Net Income
$133 million
Pretax Margin
8.87%

Debt

Sales & Book Value

Annual Sales
$1.96 billion
Cash Flow
$7.63 per share
Book Value
$45.37 per share

Miscellaneous

Free Float
24,530,000
Market Cap
$2.61 billion
Optionable
Optionable
Beta
1.16

Social Links

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

  • Mr. Patrick S. WilliamsMr. Patrick S. Williams (Age 58)
    President, CEO & Director
    Comp: $3.94M
  • Mr. Ian Philip Cleminson (Age 57)
    Executive VP & CFO
    Comp: $1.09M
  • Dr. Philip J. Boon (Age 64)
    COO & Executive VP
    Comp: $955.19k
  • Dr. Ian M. McRobbie (Age 74)
    Chief Technology Officer and Senior VP of Research & Technology
    Comp: $745.37k
  • Mr. David Bentley Jones (Age 53)
    Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary
    Comp: $846.46k
  • Mr. Graeme Blair (Age 40)
    Head of Group Finance
  • Dr. Corbin Barnes (Age 50)
    Senior Vice President of Corporate Development & Investor Relations
  • Mr. Trey Griffin (Age 57)
    Senior Vice President of Human Resources
  • Mr. Thomas C. Entwistle
    President of Oilfield Services - Americas
  • Mr. Steven W. Williams (Age 67)
    Executive Director














IOSP Stock Analysis - Frequently Asked Questions

How have IOSP shares performed in 2023?

Innospec's stock was trading at $102.86 at the beginning of the year. Since then, IOSP shares have increased by 2.0% and is now trading at $104.87.
View the best growth stocks for 2023 here
.

Are investors shorting Innospec?

Innospec saw a decline in short interest in November. As of November 15th, there was short interest totaling 139,400 shares, a decline of 7.4% from the October 31st total of 150,600 shares. Based on an average daily volume of 76,200 shares, the days-to-cover ratio is presently 1.8 days. Approximately 0.6% of the company's stock are short sold.
View Innospec's Short Interest
.

When is Innospec's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 20th 2024.
View our IOSP earnings forecast
.

How were Innospec's earnings last quarter?

Innospec Inc. (NASDAQ:IOSP) posted its quarterly earnings results on Tuesday, November, 7th. The specialty chemicals company reported $1.59 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.45 by $0.14. The specialty chemicals company earned $464.10 million during the quarter, compared to analysts' expectations of $481.17 million. Innospec had a trailing twelve-month return on equity of 12.54% and a net margin of 6.45%. Innospec's quarterly revenue was down 9.5% on a year-over-year basis. During the same period last year, the firm posted $1.74 earnings per share.

How often does Innospec pay dividends? What is the dividend yield for Innospec?

Innospec declared a Semi-Annual dividend on Monday, November 6th. Stockholders of record on Monday, November 20th will be paid a dividend of $0.72 per share on Monday, November 27th. This represents a dividend yield of 1.4%. The ex-dividend date of this dividend is Friday, November 17th. This is a boost from the stock's previous Semi-Annual dividend of $0.69.
Read our dividend analysis for IOSP
.

Is Innospec a good dividend stock?

Innospec (NASDAQ:IOSP) pays an annual dividend of $1.44 per share and currently has a dividend yield of 1.36%. The company has been increasing its dividend for 3 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 28.35%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, IOSP will have a dividend payout ratio of 21.82% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for IOSP.

What is Patrick S. Williams' approval rating as Innospec's CEO?

12 employees have rated Innospec Chief Executive Officer Patrick S. Williams on Glassdoor.com. Patrick S. Williams has an approval rating of 96% among the company's employees. This puts Patrick S. Williams in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Innospec own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Innospec investors own include NVIDIA (NVDA), Altria Group (MO), Ecolab (ECL), Eastman Chemical (EMN), Corning (GLW), Realty Income (O), Pfizer (PFE), Sherwin-Williams (SHW), Weyerhaeuser (WY) and Applied Materials (AMAT).

Who are Innospec's major shareholders?

Innospec's stock is owned by many different institutional and retail investors. Top institutional investors include Allspring Global Investments Holdings LLC (9.65%), Victory Capital Management Inc. (4.58%), Charles Schwab Investment Management Inc. (1.20%), Bank of New York Mellon Corp (1.06%), Morgan Stanley (0.81%) and Eagle Asset Management Inc. (0.76%). Insiders that own company stock include Brian Watt, Claudia Poccia, Corbin Barnes, David B Jones, David Landless, Ian Cleminson, Ian Malcolm Mcrobbie, Larry Padfield, Leslie J Parrette, Milton C Blackmore, Patrick Williams and Philip John Boon.
View institutional ownership trends
.

How do I buy shares of Innospec?

Shares of IOSP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:IOSP) was last updated on 11/29/2023 by MarketBeat.com Staff

My Account -